Filing Details
- Accession Number:
- 0001209191-15-022578
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-04 19:22:28
- Reporting Period:
- 2015-03-04
- Filing Date:
- 2015-03-04
- Accepted Time:
- 2015-03-04 19:22:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1411158 | Anacor Pharmaceuticals Inc. | ANAC | Pharmaceutical Preparations (2834) | 251854385 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1571820 | Sanjay Chanda | C/O Anacor Pharmaceuticals, Inc. 1020 East Meadow Circle Palo Alto CA 94303 | Svp, Drug Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-03-04 | 4,952 | $7.25 | 34,039 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-03-04 | 4,952 | $45.00 | 29,087 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-03-04 | 48 | $7.55 | 29,135 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-03-04 | 48 | $45.00 | 29,087 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2015-03-04 | 4,952 | $7.25 | 4,952 | $7.25 |
| Common Stock | Stock Option (right to buy) | Disposition | 2015-03-04 | 48 | $7.55 | 48 | $7.55 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-03-26 | No | 4 | M | Direct | |
| 13,552 | 2020-08-20 | No | 4 | M | Direct |
Footnotes
- This sale was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person.
- This option is fully vested and exercisable.
Billionaire Hedge Funds
